Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

Clinical trial NCT06430424 · RECRUITING

Trial details

NCT number: NCT06430424
Sponsor: University Hospital, Bordeaux
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsed Cancer Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Start date: 2024-04-05
Primary completion: 2025-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.